Scientific Advisory Council

Gregory H. Reaman, MD

Associate Director, Oncology Sciences
Office of Hematology and Oncology Products, OND
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Washington, DC

Dr. Gregory Reaman

Gregory H. Reaman, MD joined the Center for Drug Evaluation and Research, Office of New Drugs, U.S. Food and Drug Administration as the Associate Director for Oncology Sciences of the Office of Hematology and Oncology Products (OHOP) in 2011. He is the Founding and Immediate Past Chair of the Children’s Oncology Group (COG) having served in this capacity from 2000 through 2010 and previously served as Vice Chair for Scientific Affairs and Associate Chair for New Agent Studies of the legacy Children’s Cancer Group (CCG) where he directed the Phase 1 Consortium for 10 years.

Dr. Reaman is a Professor of Pediatrics at George Washington University School of Medicine and Health Sciences and a member of the Division of Hematology-Oncology at the Children’s National Medical Center in Washington, DC, which he directed for more than 17 years. He serves or has served on numerous Editorial Boards and is the author/co-author of more than 350 peer – reviewed manuscripts and 20 book chapters and the editor/associate editor of 4 textbooks. His research interests are in the biology and treatment of childhood acute leukemia and new drug development for pediatric cancer.

Pin It on Pinterest

Scroll to Top